Total Payments
$1,788
2024 Payments
$333.69
Companies
22
Transactions
38
Medicare Patients
2,059
Medicare Billing
$217,316
Payment Breakdown by Category
Food & Beverage$1,475 (82.5%)
Education$313.12 (17.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,475 | 31 | 82.5% |
| Education | $313.12 | 7 | 17.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $473.18 | 5 | $0 (2024) |
| Foundation Medicine, Inc. | $239.58 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $218.25 | 4 | $0 (2023) |
| Amgen Inc. | $162.27 | 3 | $0 (2024) |
| Seagen Inc. | $111.00 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $106.14 | 2 | $0 (2018) |
| Novocure Inc. | $90.21 | 2 | $0 (2018) |
| INTUITIVE SURGICAL, INC. | $75.25 | 1 | $0 (2024) |
| PFIZER INC. | $43.06 | 3 | $0 (2024) |
| Genentech USA, Inc. | $37.13 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $333.69 | 6 | Amgen Inc. ($106.54) |
| 2023 | $410.81 | 4 | E.R. Squibb & Sons, L.L.C. ($250.83) |
| 2022 | $111.00 | 1 | Seagen Inc. ($111.00) |
| 2019 | $143.84 | 8 | Genentech USA, Inc. ($37.13) |
| 2018 | $404.37 | 15 | Astellas Pharma US Inc ($106.14) |
| 2017 | $384.54 | 4 | Foundation Medicine, Inc. ($239.58) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $16.00 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/12/2024 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $16.00 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/18/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 09/17/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $75.25 | General |
| Category: SURGERY | ||||||
| 08/13/2024 | Amgen Inc. | IMDELLTRA (AMG 757) (Biological) | Food and Beverage | In-kind items and services | $106.54 | General |
| Category: Hematology | ||||||
| 01/18/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $104.90 | General |
| Category: Oncology | ||||||
| 10/11/2023 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Oncology | ||||||
| 09/14/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $128.12 | General |
| Category: Oncology | ||||||
| 04/23/2023 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Oncology | ||||||
| 04/18/2023 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $122.71 | General |
| Category: Hematology | ||||||
| 05/25/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $111.00 | General |
| Category: Oncology | ||||||
| 10/15/2019 | PFIZER INC. | INLYTA (Drug), BAVENCIO, LORBRENA | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $23.43 | General |
| 05/16/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: BioOncology | ||||||
| 05/01/2019 | Genentech USA, Inc. | Perjeta (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: BioOncology | ||||||
| 02/27/2019 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Hematology | ||||||
| 02/13/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Oncology | ||||||
| 02/06/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Oncology | ||||||
| 01/09/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 12/06/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Oncology | ||||||
| 11/28/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Oncology | ||||||
| 11/06/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Education | In-kind items and services | $6.19 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Oncology | ||||||
| 07/10/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: Oncology | ||||||
| 05/16/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 457 | 785 | $195,289 | $64,012 |
| 2022 | 6 | 519 | 770 | $155,762 | $57,928 |
| 2021 | 9 | 383 | 567 | $87,123 | $40,439 |
| 2020 | 7 | 700 | 976 | $210,940 | $54,938 |
Total Patients
2,059
Total Services
3,098
Medicare Billing
$217,316
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 443 | $92,841 | $30,202 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 205 | $63,679 | $21,134 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $20,380 | $6,631 | 32.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $13,835 | $4,534 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 32 | $4,554 | $1,511 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 326 | $59,634 | $22,646 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 135 | $37,629 | $14,397 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $18,106 | $6,222 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 132 | $15,009 | $5,797 | 38.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $7,174 | $2,725 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 22 | $6,295 | $2,268 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 28 | $5,413 | $1,861 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 30 | 30 | $3,876 | $1,206 | 31.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 11 | $2,626 | $806.29 | 30.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 164 | $24,702 | $12,117 | 49.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 192 | $18,714 | $9,050 | 48.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 48 | 62 | $13,121 | $6,794 | 51.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $13,520 | $5,326 | 39.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $8,759 | $3,614 | 41.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $2,717 | $1,068 | 39.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 20 | $2,243 | $1,021 | 45.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 12 | $2,093 | $905.04 | 43.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 19 | 20 | $1,254 | $544.40 | 43.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 171 | 321 | $80,314 | $18,230 | 22.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 67 | 88 | $31,249 | $7,452 | 23.8% |
About Dr. Clinton Morgan, MD
Dr. Clinton Morgan, MD is a Internal Medicine healthcare provider based in Lewiston, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2009. The National Provider Identifier (NPI) number assigned to this provider is 1376779413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clinton Morgan, MD has received a total of $1,788 in payments from pharmaceutical and medical device companies, with $333.69 received in 2024. These payments were reported across 38 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,475).
As a Medicare-enrolled provider, Morgan has provided services to 2,059 Medicare beneficiaries, totaling 3,098 services with total Medicare billing of $217,316. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Lewiston, ID
- Active Since 06/03/2009
- Last Updated 10/20/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376779413
Products in Payments
- OPDIVO (Biological) $333.02
- FOUNDATIONONE (Device) $239.58
- RYBREVANT (Drug) $159.98
- Pomalyst (Drug) $122.71
- TIVDAK (Biological) $111.00
- IMDELLTRA (AMG 757) (Biological) $106.54
- Da Vinci Surgical System (Device) $75.25
- Oncology (Device) $59.92
- IMBRUVICA (Drug) $58.27
- XGEVA (Biological) $36.88
- Lenvima (Drug) $32.17
- BOSULIF (Drug) $32.00
- Optune (Device) $30.29
- ADCETRIS (Biological) $27.64
- TECENTRIQ (Biological) $20.82
- LYNPARZA (Drug) $20.58
- Tavalisse (Drug) $20.17
- CYRAMZA (Drug) $19.61
- Kyprolis (Biological) $18.85
- Cabometyx (Drug) $18.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lewiston
Yahya Hashmi, Md, MD
Internal Medicine — Payments: $10,104
Internal Medicine $10,104
Dr. Philip Sauvageau, M.d, M.D
Internal Medicine — Payments: $6,873
Internal Medicine $6,873
Tai Ho Shin, Md, MD
Internal Medicine — Payments: $6,556
Internal Medicine $6,556
Dr. Barbara Davis, Md, MD
Internal Medicine — Payments: $1,696
Internal Medicine $1,696
Patricia Brady, Md, MD
Internal Medicine — Payments: $1,488
Internal Medicine $1,488
Dr. Gregory English, Do, DO
Internal Medicine — Payments: $816.69
Internal Medicine $816.69